• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Trending:
  • Kashmir
  • Elections
Saturday, June 6, 2026

Daily Times

Your right to know

  • HOME
  • Latest
  • Iran-Israel war
  • Gilgit Baltistan Election
  • Pakistan
    • Balochistan
    • Gilgit Baltistan
    • Khyber Pakhtunkhwa
    • Punjab
    • Sindh
  • World
  • Editorials & Opinions
    • Editorials
    • Op-Eds
    • Commentary / Insight
    • Perspectives
    • Cartoons
    • Letters to the Editor
    • Featured
    • Blogs
      • Pakistan
      • World
      • Lifestyle
      • Culture
      • Sports
  • Business
  • Sports
  • E-PAPER
    • Lahore
    • Islamabad
    • Karachi

Reuters

China aims to vaccinate 40% of population by end-July: senior adviser

Published on: March 2, 2021 12:26 PM

china

BEIJING  – China aims to vaccinate 40% of its population against COVID-19 by the end of July, a senior health adviser said on Tuesday, requiring a significant increase in inoculations even as it ramps up exports of vaccines.

Zhong Nanshan, a coronavirus expert who helped shape China’s COVID-19 response, said on Monday the current ratio of vaccine doses administered per 100 people in China is 3.56, much lower than those in Israel, United Arab Emirates and the United States.

In an online forum held by China’s Tsinghua University and the Washington-based Brookings Institution on Monday, Zhong said the target was 40% by the end of June, citing his contacts at the Chinese Center for Disease Control and Prevention.

However, in a phone call with media on Tuesday, Zhong clarified that 40% target would be hit in July, after taking into account the proportion of people who do not want to be vaccinated.

The 40% by the end of July would include people who have received either one dose or two doses, Zhong said. Three Chinese-made vaccines require two shots, while another one requires a single dose.

China, which has approved four locally developed coronavirus vaccines for use on the general public, had administered 50.52 million doses as of Feb. 28, Zhong said.

Authorities had aimed to vaccinate 50 million people before the Lunar New Year in February, official media outlet Global Times reported in January.

Sinovac Biotech’s vaccine has been used in mass vaccination drives in Brazil, Turkey and Indonesia. CanSino Biologics Inc has agreed to supply millions of doses to Mexico.

Filed Under: World Tagged With: China, covid, Vaccination

Submit a Comment




Primary Sidebar




Latest News

Pakistan, Russia agree to boost cooperation against illegal immigration

US Senate approves $70 billion boost for immigration enforcement

Pakistan rejects India’s comments on Gilgit-Baltistan elections

US and Iran exchange strikes near Strait of Hormuz

Alexander Zverev eases past Jakub Mensik in French Open semifinals

Pakistan

Pakistan, Russia agree to boost cooperation against illegal immigration

Pakistan rejects India’s comments on Gilgit-Baltistan elections

JAAC declared proscribed party ahead of AJK polls on July 27

Fixed tax scheme for small retailers launched to raise Rs 50bn annually

Govt cuts petrol price by Rs 4 per litre, keeps diesel’s unchanged

More Posts from this Category

Business

SBP’s ‘Go Cashless’ campaign saw Rs 34bn in digital transactions on Eid

Short-term inflation down by 0.56%

Saudi-Pak Business Council shows interest in infrastructure investment

‘Govt, allies united in efforts to craft people-centric budget’

Rupee records gain against US dollar

More Posts from this Category

World

US Senate approves $70 billion boost for immigration enforcement

US and Iran exchange strikes near Strait of Hormuz

CENTCOM space post signals wider US military footprint

More Posts from this Category




Footer

Home
Lead Stories
Latest News
Editor’s Picks

Culture
Life & Style
Featured
Videos

Editorials
OP-EDS
Commentary
Advertise

Cartoons
Letters
Blogs
Privacy Policy

Contact
Company’s Financials
Investor Information
Terms & Conditions

Facebook
Twitter
Instagram
Youtube

© 2026 Daily Times. All rights reserved.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.